Abstract:Proc Amer Assoc Cancer Res, Volume 47, 2006 3984 The epithelial components of the mammary gland are thought to arise from stem cells with the capacity for self-renewal and multilineage differentiation. These cells and/or their immediate progeny may be targets for transformation, generating tumors which are driven by cells retaining stem cell properties. We have previously shown that normal mammary stem cell self-renewal is regulated by bi-directional interactions between Hedgehog and Notch pathways with subsequent regulation of the polycomb gene Bmi-1. We have now utilized in vitro suspension based culture systems as well as NOD-SCID mouse models to examine the role of Bmi-1 in regulating human mammary stem cell self-renewal. qRT-PCR demonstrates that Bmi-1 is highly expressed in primitive human mammary cells cultured in mammospheres compared to differentiated cells cultured on collagen substrata. Overexpression of Bmi-1 with a lentivirus vector increases mammosphere initiating cells by 77% and mammosphere size by 61%. In contrast, down regulation of Bmi-1 expression with siRNA lentiviruses reduces mammosphere formation by 80% and mammosphere size by 60%. Inhibiting Bmi-1 expression also abrogates the stimulatory effects of Hedgehog and Notch signaling on mammosphere formation. Modulation of Bmi-1 expression in mammosphere initiating cells altered their mammary gland outgrowth in humanized fat pads of NOD-SCID mice. Interestingly, “tumor stem cells” characterized as CD44+CD24-/lowLin- displayed an 8-fold increase in Bmi-1 expression compared to non-tumorigenic CD44+CD24+Lin- cells isolated from the same human mammary tumor. These studies support a “tumor stem cell model” in which Bmi-1 plays an important role in the self-renewal of both normal and tumorigenic mammary stem cells with disregulation of Bmi-1 promoting carcinogenesis. Since tumor stem cells may drive tumor formation, targeting components of Bmi-1 regulated pathways represents a rationale strategy to eliminate this important cancer cell population.

Bmi-1 Regulates the Differentiation and Clonogenic Self-renewal of I-type Neuroblastoma Cells in a Concentration-dependent Manner

Bmi-1 is Essential for the Tumorigenicity of Neuroblastoma Cells

Bmi-1 Regulates Self-Renewal Of Normal And Malignant Human Mammary Stem Cells

Bmi-1 Expression Modulates Non-Small Cell Lung Cancer Progression.

Collaborative ISL1/GATA3 interaction in controlling neuroblastoma oncogenic pathways overlapping with but distinct from MYCN.

Bmi1 overexpression in the cerebellar granule cell lineage of mice affects cell proliferation and survival without initiating medulloblastoma formation

Distinctive mesenchymal-like neurofibroma stem cells shape NF1 clinical phenotypes controlled by BDNF microenvironment

NeuroD1 Dictates Tumor Cell Differentiation in Medulloblastoma.

The Non-Cell-autonomous Function of ID1 Promotes AML Progression Via ANGPTL7 from the Microenvironment.

The Crucial Roles of Bmi-1 in Cancer: Implications in Pathogenesis, Metastasis, Drug Resistance, and Targeted Therapies

Bmi-1, Stem Cells and Cancer

The Polycomb Group Transcriptional Repressor Bmi-1 is Constitutively Expressed in Multiple Myeloma (MM) Cells and Modulates Proliferation Through a Mechanism Independent of the Ink4a/ARF Locus.

Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells

Bmi-1 Regulates Self-Renewal, Proliferation and Senescence of Human Fetal Neural Stem Cells in Vitro

BMI-1, a promising therapeutic target for human cancer.

IGFBP2 promotes neural stem cell maintenance and proliferation differentially associated with glioblastoma subtypes

Direct effects of Bmi1 on p53 protein stability inactivates oncoprotein stress responses in embryonal cancer precursor cells at tumor initiation

Bmal1 regulates the stemness and tumorigenesis of gliomas with the Wnt/β-catenin signaling pathway

Knockdown of Bmi1 Inhibits the Stemness Properties and Tumorigenicity of Human Bladder Cancer Stem Cell-Like Side Population Cells

MYT1 Attenuates Neuroblastoma Cell Differentiation by Interacting with the LSD1/CoREST Complex

Sox2 Promotes Tumorigenicity and Inhibits the Differentiation of I-Type Neuroblastoma Cells